NCT03449732

Brief Summary

After conduction a pilot study, pupillary dilation reflex (PDR) is measured in response to nociceptive stimulation perioperatively in infants, children and adolescents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 28, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

March 30, 2018

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

3.1 years

First QC Date

February 22, 2018

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stimulation Intensity

    Necessary stimulation intensity to dilate the pupil more than 13%

    During pupil measurements in the perioperative period

Secondary Outcomes (3)

  • Pupillary Pain Index score

    During pupil measurements in the perioperative period

  • Blood pressure

    During PDR measurements

  • Heart rate

    During PDR measurements

Study Arms (3)

PDR measurement group A

EXPERIMENTAL

Two measurements of PDR perioperatively before and after opioid administration in toddlers (28 days until 23 months)

Device: PDR measurement

PDR measurement group B

EXPERIMENTAL

Two measurements of PDR perioperatively before and after opioid administration in children (2 until 11 years)

Device: PDR measurement

PDR measurement group C

EXPERIMENTAL

Two measurements of PDR perioperatively before and after opioid administration in adolescents (12 until 18 years)

Device: PDR measurement

Interventions

PDR measurement at two standardized times perioperatively: 1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached 2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth

Also known as: PPI assessment
PDR measurement group APDR measurement group BPDR measurement group C

Eligibility Criteria

Age28 Days - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Scheduled abdominal, urological or otorhinolaryngology surgery under general anaesthesia
  • ASA I-II

You may not qualify if:

  • History of eye deformity, invasive ophthalmologic surgery
  • Known cranial nerve(s) deficit
  • Infection of the eye
  • Predicted difficult airway management (Paediatric Difficult Airway Guidelines - Difficult Airway Society)
  • Chronic opioid use (\>3 months)
  • Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine
  • Preoperatively administrated benzodiazepins or antiemetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital Antwerp

Edegem, Antwerp, 2650, Belgium

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nathalie Kegels, MD

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR
  • Vera Saldien, MD

    University Hospital, Antwerp

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

February 22, 2018

First Posted

February 28, 2018

Study Start

March 30, 2018

Primary Completion

April 26, 2021

Study Completion

December 31, 2021

Last Updated

May 18, 2022

Record last verified: 2022-05

Locations